Synthesis, crystal structure, and <i>in vitro</i> evaluation of newer 2,4-thiazolidinedione hybrids as α-glucosidase inhibitors
In conclusion, compound <b>6f</b> could be considered a promising lead compound for further optimization in AGI development for the treatment of T2DM.
Authors
- Arnab Sarkar (ORCID: https://orcid.org/0000-0002-7354-2092)
- Avik Maji (ORCID: https://orcid.org/0000-0002-6873-6976)
- Akash De
- Tapan Kumar Maity (ORCID: https://orcid.org/0000-0002-3245-7297)
- Abhik Paul (ORCID: https://orcid.org/0000-0002-7931-7507)
- Ajeya Samanta (ORCID: https://orcid.org/0000-0001-9360-6092)
- Uday Shee (ORCID: https://orcid.org/0000-0003-1039-734X)
- Sanmoy Karmakar (ORCID: https://orcid.org/0000-0003-2162-5061)
- Sai Satyaprakash Mishra
- Md. Adil Shaharyar (ORCID: https://orcid.org/0000-0003-4648-1842)
Institutions
- Jadavpur University (IN)
Publication Details
- Journal
- Future Medicinal Chemistry
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1080/17568919.2025.2550933
- Primary Topic
- Natural Antidiabetic Agents Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00